Researchers developed and tested a prediction model to estimate the risk of bladder stones in men with benign prostatic hyperplasia (BPH) who had prostate surgery. The study included 446 patients from a single center, using data from 2023 to 2025.
The model showed excellent ability to distinguish between patients who developed stones and those who did not, with scores of 0.865 in the training group and 0.882 in the validation group. It also calibrated well, meaning its predicted risks matched actual outcomes.
This was a retrospective, observational study, and the model was only tested within the same hospital. It does not prove the model prevents stones or improves health outcomes. Safety events were not reported, as the study focused on prediction, not treatment.
The main reason to be careful is that the model needs external validation in other hospitals before it can guide widespread clinical decisions. Readers should see this as an early tool that may help personalize monitoring, not as a proven way to reduce stone risk.